Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04774952
Title Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Revolution Medicines, Inc.
Indications

Advanced Solid Tumor

Therapies

RMC-5552

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UC Irvine - Chao Family Comprehensive Cancer Center Recruiting Irvine California 92868 United States Details
UC Davis Comprehensive Cancer Center Not yet recruiting Sacramento California 95817 United States Details
UC San Francisco - Helen Diller Family Comprehensive Cancer Center Recruiting San Francisco California 94115 United States Details
Moffitt Cancer Center Recruiting Tampa Florida 33612 United States Details
Memorial Sloan Kettering Cancer Center Recruiting New York New York 10021 United States Details
University of Oklahoma - Stephenson Cancer Center Recruiting Oklahoma City Oklahoma 73104 United States Details
Sarah Cannon Research Institute - Tennessee Oncology, PLLC Recruiting Nashville Tennessee 37203 United States Details
Dell Seton Medical Center at University of Texas Recruiting Austin Texas 78712 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field